Reduced bone marrow toxicity of neocarzinostatin by conjugation with divinyl ether-maleic acid copolymer
- 1 March 1990
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (3) , 253-260
- https://doi.org/10.1016/0277-5379(90)90219-j
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Protein Binding of Macromolecular Anticancer Agent SMANCS: Characterization of Poly(styrene-co-maleic acid) Derivatives as an Albumin Binding LigandJournal of Bioactive and Compatible Polymers, 1988
- Improvement of Pharmacological Properties of Protein-Drugs by Tailoring with Synthetic PolymersJournal of Bioactive and Compatible Polymers, 1988
- Medial regression and its functional significance in tumor-supplying host arteries. A morphometric study of hepatic arteries in human livers with hepatocellular carcinomaCancer, 1987
- Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodiesNature, 1985
- Conjugation of poly(styrene-co-maleic acid) derivatives to the antitumor protein neocarzinostatin: pronounced improvements in pharmacological propertiesJournal of Medicinal Chemistry, 1985
- Subcellular Action of NeocarzinostatinThe Journal of Biochemistry, 1980
- Lymphotropic accumulation of an antitumor antibiotic protein, neocarzinostatinPublished by Elsevier ,1980
- A LIPOPHILIC DERIVATIVE OF NEOCARZINOSTATIN A Polymer Conjugation of an Antitumor Protein Antibiotic*International Journal of Peptide and Protein Research, 1979
- Divinyl Ether-Maleic Anhydride (Pyran) Copolymer used to demonstrate the Effect of Molecular Weight on Biological ActivityNature, 1973
- Interferon Induction in Man by a Synthetic Polyanion of Defined CompositionNew England Journal of Medicine, 1967